Cutting edge: Innate immunity conferred by B cells is regulated by caspase-8

Journal of Immunology

Volumn 175, Issue 6, 2005, Pages 3469-3473

  Beisner, Daniel R ^a   Ch'en, Irene L ^b   Kolla, Ravi V ^c   Hoffmann, Alexander ^d   Hedrick, Stephen M ^a,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b BURNHAM INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CPG DNA; DNA; DOUBLE STRANDED RNA; FAS ASSOCIATED DEATH DOMAIN PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; LIGAND; LIPOPOLYSACCHARIDE; LYMPHOCYTE ANTIGEN RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN BINDING; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CPG ISLAND; ENZYME REGULATION; EXON; FLOW CYTOMETRY; GENE ACTIVATION; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; WESTERN BLOTTING;

EID: 24744459035     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.6.3469     Document Type: Article

References (23)

1. Peter, M. E., and P. H. Krammer. 1998. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr. Opin. Immunol. 10: 545-551.
2. Walsh, C. M., B. G. Wen, A. M. Chinnaiyan, K. O'Routke, V. M. Dixit, and S. M. Hedrick. 1998. A role for FADD in T cell activation and development. Immunity 8: 439-449.
3. Newton, K., A. W. Harris, M. L. Barh, K. G. C. Smith, and A. Srrasser. 1998. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 17: 706-718.
4. Zhang, J., D. Cado, A. Chen, N. H. Kabra, and A. Winoto. 1998. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392: 296-300.
5. Salmena, L., B. Lemmeis, A. Hakem, E. Matysiak-Zablocki, K. Murakami, P. Y. Au, D. M. Berry, L. Tamblyn, A. Shehabeldin, E. Migon, et al. 2003. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev. 17: 883-895.
6. Beisner, D. R., I. H. Chu, A. F. Arechiga, S. M. Hedrick, and C. M. Walsh. 2003. The requirements fot Fas-associated death domain signaling in mature T cell activation and survival. J. Immunol. 171:247-256.
7. Kang, T. B., T. Ben-Moshe, E. E. Varfolomeev, Y. Pewmer-Jung, N. Yogev, A. Jutewicz, A. Waisman, O. Brenner, R. Haffner, E. Gustafsson, et al. 2004. Caspase-8 serves both apoptotic and nonapoptotic roles. J. Immunol. 173: 2976-2984.
8. Chun, H. J., L. Zheng, M. Ahmad, J, Wang, C. K. Speirs, R. M. Siegel, J. K. Dale, J. Puck, J. Davis, C. G. Hall, et al. 2002. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419: 395-399.
9. Su, H., N. Bidere, L. Zheng, A. Cubre, K. Sakai, J. Dale, L. Salmena, R. Hakem, S. Straus, and M. Lenardo. 2005. Requirement for caspase-8 in NF-κB activation by antigen receptor. Science 307: 1465-1468.
10. Rickert, R. C., J. Roes, and K. Rajewsky. 1997. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25: 1317-1318.
11. Hsing, Y., B. S. Hostager, and G. A. Bishop. 1997. Characterization of CD40 signaling determinants regulating nuclear factor-κB activation in B lymphocytes. J. Immunol. 159: 4898-4906.
12. Schopf, L. R., J. L. Bliss, L. M. Lavigne, C. L. Chung, S. F. Wolf, and J. P. Sypek. 1999. Interleukin-12 is capable of generatingan antigen-specific Th1-type response in the presence of an ongoing infection-driven Th2-type response. Infect. Immun. 67: 2166-2171.
13. Hedrick, S. M., L. A. Matis, T. T. Hecht, L. E. Samelson, D. L. Longo, E. Heber-Katz, and R. H. Schwartz. 1982. The fine specificity of antigen and Ia determinant recognition by T cell hybridoma clones specific for pigeon cytochrome c. Cell 30: 141-152.
14. Varfolomeev, E. E., M. Schuchmann, V. Luria, N, Chiannilkulchai, J. S. Beckmann, I. L. Mett, D. Rebrikov, V. M. Brodianski, O. C. Kemper, O. Kollet, et al. 1998. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9: 267-276.
15. Palombella, V.J., O. J. Rando, A. L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proreasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78: 773-785.
16. Sun, S. C., P. A. Ganchi, D. W. Ballard, and W. C. Greene. 1993. NF-κB controls expression of inhibitor IκBα: evidence for an inducible auto regulatory pathway. Science 259: 1912-1915.
17. Lee, H. H., H. Dadgostar, Q. Cheng, J. Shu, and G. Cheng. 1999. NF-κB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA 96: 9136-9141.
18. Hay, B. A., J. R. Huh, and M. Guo. 2004. The genetics of cell death: approaches, Insights and opportunities in Drosophila. Nat. Rev. Genet. 5: 911-922.
19. Green, D. R., and G. Kroemer. 2004. The pathophysiology of mitochondrial cell death. Science 305:626-629.
20. Danial, N. N., and S. J. Korsmeyer. 2004. Cell death: critical control points. Cell 116: 205-219.
21. + T cell activation through caspase-8-dependent NF-κB activation. J. Immunol. 174: 5270-5278.
22. Rathore, N., H. Matra, and P. M. Chaudhary. 2004. An evolutionary conserved pathway of nuclear factor-κB activation involving caspase-mediated cleavage and N-end rule pathway-mediated degradation of IκBα. J. Biol. Chem. 279: 39358-39365.
23. Pellegrini, M., S. Bath, V. S. Marsden, D. C. Huang, D. Metcalf, A. W. Harris, and A. Strasser. 2005. FADD and caspase-8 are required for cytokine-induced proliferation of hemopoietic progenitor cells. Blood 000:000-000.